Innovative application of allosteric modulators of adenosine a1 receptors for the prevention and treatment of stroke and myocardial infarction

Project Information

KOUROUNAKIS ANGELIKI

Grant agreement ID: QLK6-CT-1999-51170

Project closed

Start date 17 January 2000

End date 16 January 2001

Funded under

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Total cost € 51 600,00

EU contribution € 51 600,00

Coordinated by

ARISTOTLE UNIVERSITY OF THESSALONIKI
Greece

Objective

Evaluation of a novel series of allosteric modulators, compounds that enhance adenosine A1 agonist binding and function, in combination with antioxidants, in in-vitro/in-vivo models of ischemic-reperfusion injury.

Fields of science

• medical and health sciences › basic medicine › neurology › stroke

Programme(s)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Topic(s)

• 1.1.1.-6. - Key action The Ageing Population and Disabilities

Call for proposal

Data not available

Funding Scheme

RGI - Research grants (individual fellowships)

Coordinator

ARISTOTLE UNIVERSITY OF THESSALONIKI

• EU contribution: No data
• Address: University Building Administration Building ; 54006 THESSALONKI ; Greece
• Total cost: No data